1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Development/Innovation Trends
4. Value Added Insights
4.1. Disease Epidemiology of Coronary Artery Disease (CAD)
4.2. Regulatory Scenario, by Country
4.3. Coronary Angiography Volume Analysis
4.4. Comparative Assessment
4.5. Reimbursement Scenario
4.6. Clinical Trials Analysis
4.7. Technology Roadmap
4.8. Patient Diagnostics Journey
4.9. Product Adoption Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Healthcare Expenditure Outlook
5.1.2. Global Diagnostic Tools Market Overview
5.2. Forecast Factors – Relevance & Impact
5.2.1. Prevalence of Cardiovascular Diseases (CVDs)
5.2.2. Growing Healthcare Expenditure
5.2.3. Increasing Market Consolidation Activities in the Cardiology Industry
5.2.4. Cost Impact
5.2.5. Increasing Application of Fractional Flow Reserve Computed Tomography
5.2.6. Improvement Diagnostic Accuracy
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Demand Value or Size (US$ Mn) Analysis 2017-2022 and Forecast, 2023–2033
6.1. Historical Market Value (US$ Mn) Analysis, 2017-2022
6.2. Current and Future Market Value (US$ Mn) Projections, 2023–2033
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Global Market Analysis 2017-2022 and Forecast 2023–2033, By Scan
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Scan, 2017-2022
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Scan, 2023–2033
7.3.1. Obstructive CAD
7.3.2. Non-obstructive CAD
7.4. Market Attractiveness Analysis By Scan
8. Global Market Analysis 2017-2022 and Forecast 2023–2033, By End User
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By End User, 2017-2022
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2023–2033
8.3.1. Hospitals
8.3.2. Diagnostic Imaging Centers
8.3.3. Cardiology Clinics
8.4. Market Attractiveness Analysis By End User
9. Global Market Analysis 2017-2022 and Forecast 2023–2033, By Region
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2017-2022
9.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2023–2033
9.3.1. North America
9.3.2. Europe
9.3.3. Japan
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2017-2022 and Forecast 2023–2033
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2017-2022
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033
10.3.1. By Country
10.3.1.1. U.S.
10.3.1.2. Canada
10.3.2. By Scan
10.3.3. By End User
10.4. Market Attractiveness Analysis
10.4.1. By Country
10.4.2. By Scan
10.4.3. By End User
10.5. Market Trends
10.6. Key Market Participants – Intensity Mapping
10.7. Drivers and Restraints – Impact Analysis
10.8. Country Level Analysis & Forecast
10.8.1. U.S. Market Analysis
10.8.1.1. Introduction
10.8.1.2. Market Analysis and Forecast by Market Taxonomy
10.8.1.2.1. By Scan
10.8.1.2.2. By End User
10.8.2. Canada Market Analysis
10.8.2.1. Introduction
10.8.2.2. Market Analysis and Forecast by Market Taxonomy
10.8.2.2.1. By Scan
10.8.2.2.2. By End User
11. Europe Market 2017-2022 and Forecast 2023-2033
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2022
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033
11.3.1. By Country
11.3.1.1. Germany
11.3.1.2. U.K
11.3.1.3. France
11.3.1.4. Italy
11.3.1.5. Netherland
11.3.1.6. Rest of Europe
11.3.2. By Scan
11.3.3. By End User
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Scan
11.4.3. By End User
11.5. Market Trends
11.6. Key Market Participants – Intensity Mapping
11.7. Drivers and Restraints – Impact Analysis
11.8. Country Level Analysis & Forecast
11.8.1. Germany Market Analysis
11.8.1.1. Introduction
11.8.1.2. Market Analysis and Forecast by Market Taxonomy
11.8.1.2.1. By Scan
11.8.1.2.2. By End User
11.8.2. UK Market Analysis
11.8.2.1. Introduction
11.8.2.2. Market Analysis and Forecast by Market Taxonomy
11.8.2.2.1. By Scan
11.8.2.2.2. By End User
11.8.3. France Market Analysis
11.8.3.1. Introduction
11.8.3.2. Market Analysis and Forecast by Market Taxonomy
11.8.3.2.1. By Scan
11.8.3.2.2. By End User
11.8.4. Italy Market Analysis
11.8.4.1. Introduction
11.8.4.2. Market Analysis and Forecast by Market Taxonomy
11.8.4.2.1. By Scan
11.8.4.2.2. By End User
11.8.5. Netherland Market Analysis
11.8.5.1. Introduction
11.8.5.2. Market Analysis and Forecast by Market Taxonomy
11.8.5.2.1. By Scan
11.8.5.2.2. By End User
12. Japan Market Analysis 2017-2022 and Forecast 2023–2033
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2022
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033
12.3.1. By Scan
12.3.2. By End User
12.3.3. Market Attractiveness Analysis
12.3.4. By Scan
12.3.5. By End User
12.4. Market Trends
12.5. Key Market Participants – Intensity Mapping
12.6. Drivers and Restraints – Impact Analysis
12.7. Country Level Analysis & Forecast
13. Market Structure Analysis
13.1. Market Analysis by Tier of Companies
13.2. Market Share Analysis of Top Players (%)
13.3. Market Presence Analysis
13.3.1. By Regional Footprint of Players
13.3.2. Product Footprint of Players
13.3.3. Channel Footprint of Players
14. Competition Analysis
14.1. Competition Dashboard
14.2. Branding and Promotional Strategies, By Key Players
14.3. Key Development Analysis
14.4. Competition Deep Dive
14.4.1. Heartflow Inc.
14.4.1.1. Overview
14.4.1.2. Product Portfolio
14.4.1.3. Key Financials
14.4.1.4. SWOT Analysis
14.4.1.5. Key Developments
14.4.1.6. Sales Footprint
14.4.1.7. Strategy Overview
14.4.1.7.1. Marketing Strategy
14.4.1.7.2. Product Strategy
14.4.1.7.3. Channel Strategy
14.4.2. Abbott Laboratories
14.4.2.1. Overview
14.4.2.2. Product Portfolio
14.4.2.3. Key Financials
14.4.2.4. SWOT Analysis
14.4.2.5. Key Developments
14.4.2.6. Sales Footprint
14.4.2.7. Strategy Overview
14.4.2.7.1. Marketing Strategy
14.4.2.7.2. Product Strategy
14.4.2.7.3. Channel Strategy
14.4.3. Boston Scientific Corp.
14.4.3.1. Overview
14.4.3.2. Product Portfolio
14.4.3.3. Key Financials
14.4.3.4. SWOT Analysis
14.4.3.5. Key Developments
14.4.3.6. Sales Footprint
14.4.3.7. Strategy Overview
14.4.3.7.1. Marketing Strategy
14.4.3.7.2. Product Strategy
14.4.3.7.3. Channel Strategy
14.4.4. Bracco SpA
14.4.4.1. Overview
14.4.4.2. Product Portfolio
14.4.4.3. Key Financials
14.4.4.4. SWOT Analysis
14.4.4.5. Key Developments
14.4.4.6. Sales Footprint
14.4.4.7. Strategy Overview
14.4.4.7.1. Marketing Strategy
14.4.4.7.2. Product Strategy
14.4.4.7.3. Channel Strategy
14.4.5. GE Electric Co.
14.4.5.1. Overview
14.4.5.2. Product Portfolio
14.4.5.3. Key Financials
14.4.5.4. SWOT Analysis
14.4.5.5. Key Developments
14.4.5.6. Sales Footprint
14.4.5.7. Strategy Overview
14.4.5.7.1. Marketing Strategy
14.4.5.7.2. Product Strategy
14.4.5.7.3. Channel Strategy
14.4.6. Heartflow Inc.
14.4.6.1. Overview
14.4.6.2. Product Portfolio
14.4.6.3. Key Financials
14.4.6.4. SWOT Analysis
14.4.6.5. Key Developments
14.4.6.6. Sales Footprint
14.4.6.7. Strategy Overview
14.4.6.7.1. Marketing Strategy
14.4.6.7.2. Product Strategy
14.4.6.7.3. Channel Strategy
14.4.7. Medtronic PLC
14.4.7.1. Overview
14.4.7.2. Product Portfolio
14.4.7.3. Key Financials
14.4.7.4. SWOT Analysis
14.4.7.5. Key Developments
14.4.7.6. Sales Footprint
14.4.7.7. Strategy Overview
14.4.7.7.1. Marketing Strategy
14.4.7.7.2. Product Strategy
14.4.7.7.3. Channel Strategy
14.4.8. Terumo Corporation
14.4.8.1. Overview
14.4.8.2. Product Portfolio
14.4.8.3. Key Financials
14.4.8.4. SWOT Analysis
14.4.8.5. Key Developments
14.4.8.6. Sales Footprint
14.4.8.7. Strategy Overview
14.4.8.7.1. Marketing Strategy
14.4.8.7.2. Product Strategy
14.4.8.7.3. Channel Strategy
14.4.9. B. Braun Melsungen AG
14.4.9.1. Overview
14.4.9.2. Product Portfolio
14.4.9.3. Key Financials
14.4.9.4. SWOT Analysis
14.4.9.5. Key Developments
14.4.9.6. Sales Footprint
14.4.9.7. Strategy Overview
14.4.9.7.1. Marketing Strategy
14.4.9.7.2. Product Strategy
14.4.9.7.3. Channel Strategy
14.4.10. Siemens AG
14.4.10.1. Overview
14.4.10.2. Product Portfolio
14.4.10.3. Key Financials
14.4.10.4. SWOT Analysis
14.4.10.5. Key Developments
14.4.10.6. Sales Footprint
14.4.10.7. Strategy Overview
14.4.10.7.1. Marketing Strategy
14.4.10.7.2. Product Strategy
14.4.10.7.3. Channel Strategy
14.4.11. Koninklijke Philips N.V.
14.4.11.1. Overview
14.4.11.2. Product Portfolio
14.4.11.3. Key Financials
14.4.11.4. SWOT Analysis
14.4.11.5. Key Developments
14.4.11.6. Sales Footprint
14.4.11.7. Strategy Overview
14.4.11.7.1. Marketing Strategy
14.4.11.7.2. Product Strategy
14.4.11.7.3. Channel Strategy
15. Assumptions and Acronyms Used
16. Research Methodology
Table 01: Global Market Value (US$ Mn) Analysis 2017–2033, By ScanTable 02: Global Market Value (US$ Mn) Analysis 2017–2033, By End User
Table 03: Global Market Value (US$ Mn) Analysis 2017–2033, By Region
Table 04: North America Market Value (US$ Mn) Analysis 2017–2033, By Country
Table 05: North America Market Value (US$ Mn) Analysis 2017–2033, By Scan
Table 06: North America Market Value (US$ Mn) Analysis 2017–2033, By End User
Table 07: Europe Market Value (US$ Mn) Analysis 2017–2033, By Country
Table 08: Europe Market Value (US$ Mn) Analysis 2017–2033, By Scan
Table 09: Europe Market Value (US$ Mn) Analysis 2017–2033, By End User
Table 10: Japan Market Value (US$ Mn) Analysis 2017–2033, By Country
Table 11: Japan Market Value (US$ Mn) Analysis 2017–2033, By Scan
Table 12: Japan Market Value (US$ Mn) Analysis 2017–2033, By End User
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
